Elicio Therapeutics Inc. (ELTX)
NASDAQ: ELTX
· Real-Time Price · USD
11.78
1.94 (19.72%)
At close: Aug 18, 2025, 3:59 PM
11.78
0.04%
After-hours: Aug 18, 2025, 04:10 PM EDT
Elicio Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 1.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.65M | 25.94M | 1.46M | 540K | n/a |
Cost of Revenue | 281K | 278K | 583K | 290K | 293K | 290K | 286K | n/a | n/a | 48K | 241K | 290K | n/a | 228K | 656K | 217K | 206K | n/a |
Gross Profit | -281K | -278K | 583K | -290K | -293K | -290K | -286K | n/a | n/a | -48K | -241K | -290K | n/a | 1.42M | 25.29M | 1.24M | 334K | n/a |
Operating Income | -10.09M | -10.74M | -13.48M | -10.34M | -10.92M | -10.24M | -9.39M | -10.77M | -7.78M | -7.8M | -5.96M | -5.77M | -6.23M | -14.48M | 14.63M | -15.76M | -18.24M | -6.19M |
Interest Income | 168K | 210K | 305K | 185K | 137K | 150K | 75K | 246K | 39K | 10K | 54.83K | 10K | n/a | 1.36M | 876.25K | 110K | 124K | 1.8K |
Pretax Income | -10.56M | -11.21M | -14M | -18.84M | -7.23M | -11.83M | -8.95M | -10.66M | -7.56M | -8.03M | -6.65M | -7.2M | -7.3M | -14.24M | 14.89M | -15.7M | -17.07M | -6.19M |
Net Income | -10.56M | -11.21M | -14M | -18.84M | -7.23M | -11.83M | -8.95M | -10.66M | -7.56M | -8.03M | -6.65M | -7.2M | -7.3M | -14.24M | 14.89M | -15.7M | -17.07M | -6.19M |
Selling & General & Admin | 3.08M | 2.96M | 2.77M | 3.14M | 2.74M | 2.68M | 3.23M | 3.51M | 2.83M | 2.32M | 1.67M | 1.18M | 1.19M | 4.27M | 4.01M | 3.74M | 4.16M | 1.64M |
Research & Development | 7.01M | 7.78M | 10.71M | 7.21M | 8.18M | 7.56M | 6.16M | 7.26M | 4.94M | 5.48M | 4.29M | 4.59M | 5.04M | 11.63M | 6.64M | 13.26M | 14.42M | 4.55M |
Other Expenses | -281K | -278K | -305K | -290K | -293K | -290K | -286K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 9.81M | 10.46M | 13.17M | 10.05M | 10.63M | 9.95M | 9.11M | 10.77M | 7.78M | 7.8M | 5.96M | 5.77M | 6.23M | 15.9M | 10.65M | 17M | 18.58M | 6.19M |
Interest Expense | 194K | 176K | 234K | 137K | 49K | 36K | 2K | 1K | 714K | 342K | 90.84K | 1.08M | 1.07M | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.68M | 2.92M | n/a | n/a | n/a |
Cost & Expenses | 10.09M | 10.74M | 13.48M | 10.34M | 10.92M | 10.24M | 9.39M | 10.77M | 7.78M | 7.8M | 5.96M | 5.77M | 6.23M | 16.13M | 11.31M | 17.22M | 18.78M | 6.19M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 463.52K | n/a | n/a | n/a | n/a | n/a | n/a | 1.8K |
Shares Outstanding (Basic) | 16.06M | 12.95M | 12.2M | 13.58M | 11.28M | 10.27M | 9.6M | 4.08M | 3.1M | 3.2M | 3.1M | 3.18M | 3.09M | 3M | 3M | 2.98M | 2.97M | 13.31M |
Shares Outstanding (Diluted) | 16.06M | 12.95M | 12.2M | 13.58M | 11.28M | 10.27M | 9.6M | 4.08M | 3.1M | 3.2M | 3.1M | 3.18M | 3.09M | 3M | 3M | 2.98M | 2.97M | 13.31M |
EPS (Basic) | -0.66 | -0.87 | -1.15 | -1.39 | -0.64 | -1.15 | -0.93 | -2.61 | -2.44 | -2.51 | -2.15 | -2.27 | -2.37 | -4.75 | 4.97 | -5.26 | -5.75 | -0.47 |
EPS (Diluted) | -0.66 | -0.87 | -1.15 | -1.39 | -0.64 | -1.15 | -0.93 | -2.61 | -2.44 | -2.51 | -2.15 | -2.27 | -2.37 | -4.75 | 4.97 | -5.26 | -5.75 | -0.47 |
EBITDA | -10.09M | -10.76M | -13.46M | -18.41M | -6.89M | -11.5M | -8.77M | -10.38M | -6.84M | -7.7M | -6.2M | -5.67M | -6.23M | -14.01M | 15.11M | -15.54M | -16.87M | -6.14M |
EBIT | -10.37M | -11.03M | -13.77M | -18.7M | -7.18M | -11.79M | -8.95M | -10.66M | -6.84M | -7.69M | -6.56M | -6.12M | -6.23M | -14.24M | 14.89M | -15.7M | -17.07M | -6.19M |
Depreciation & Amortization | 281K | 278K | 305K | 290K | 293K | 290K | 286K | 273K | 501K | 48K | 241K | 290K | 105.21K | 228K | 223K | 217K | 206K | 52.3K |